Zhejiang Huahai Pharmaceutical Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Net Sales

2,577.44

2,335.39

2,178.26

1,892.53

2,147.79

2,368.56

2,299.77

Other Operating Income

0.00

Total Operating income

2,577.44

2,335.39

2,178.26

1,892.53

2,147.79

2,368.56

2,299.77

Raw Material Cost

1,165.16

1,099.01

1,075.67

906.12

922.38

934.32

1,018.25

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

58.46

63.11

58.06

59.24

59.40

56.90

51.19

Selling and Distribution Expenses

676.17

748.63

624.20

692.29

751.76

794.02

773.64

Other Expenses

15.01

11.95

30.77

21.32

19.09

14.81

21.56

Total Expenditure (Excl Depreciation)

2,049.89

2,030.29

2,065.66

1,870.85

1,924.48

1,933.30

2,058.64

Operating Profit (PBDIT) excl Other Income

527.5

305.1

112.6

21.7

223.29999999999998

435.3

241.1

Other Income

59.15

246.93

8.99

53.17

49.00

43.36

105.43

Operating Profit (PBDIT)

819.78

782.07

228.04

310.09

459.21

674.85

466.20

Interest

58.46

63.11

58.06

59.24

59.40

56.90

51.19

Exceptional Items

4.82

4.78

-10.44

26.48

19.45

13.25

-17.70

Gross Profit (PBDT)

1,412.27

1,236.38

1,102.60

986.41

1,225.41

1,434.25

1,281.53

Depreciation

275.97

264.19

248.17

239.10

Profit Before Tax

490.17

447.76

-104.65

13.14

171.09

383.05

158.22

Tax

88.96

45.99

41.32

37.52

58.73

78.97

82.13

Provisions and contingencies

0.00

Profit After Tax

366.73

404.18

-113.96

-29.13

112.08

297.40

87.71

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

366.73

404.18

-113.96

-29.13

112.08

297.40

87.71

Share in Profit of Associates

0.00

Minority Interest

2.01

-5.83

-32.64

-2.10

-2.96

-1.36

-17.50

Other related items

0.00

Consolidated Net Profit

368.75

398.34

-146.60

-31.23

109.12

296.04

70.22

Equity Capital

0.00

Face Value

1.0

Reserves

9,778.58

9,846.96

9,442.68

9,509.93

9,910.30

9,779.25

8,897.78

Earnings per share (EPS)

0.25

0.27

-0.08

-0.02

0.08

0.2

0.06

Diluted Earnings per share

0.25

0.27

-0.08

-0.02

0.08

0.2

0.06

Operating Profit Margin (Excl OI)

18.8%

11.1%

-2.07%

-0.38%

7.54%

16.18%

5.29%

Gross Profit Margin

29.73%

30.99%

7.32%

14.65%

19.52%

26.65%

17.28%

PAT Margin

14.23%

17.31%

-5.23%

-1.54%

5.22%

12.56%

3.81%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 10.36% vs 7.21% in Mar 2026

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -7.43% vs 371.69% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 42.14% vs 144.34% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is -7.29% vs 8.61% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Zhejiang Huahai Pharmaceutical Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CNY)

Change(%)

Net Sales

2,577.44

Other Operating Income

0.00

Total Operating income

2,577.44

Raw Material Cost

1,165.16

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

58.46

Selling and Distribution Expenses

676.17

Other Expenses

15.01

0.00

15.01

Total Expenditure (Excl Depreciation)

2,049.89

Operating Profit (PBDIT) excl Other Income

527.55

0.00

527.55

Other Income

59.15

Operating Profit (PBDIT)

819.78

Interest

58.46

Exceptional Items

4.82

Gross Profit (PBDT)

1,412.27

Depreciation

275.97

Profit Before Tax

490.17

Tax

88.96

Provisions and contingencies

0.00

Profit After Tax

366.73

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

366.73

Share in Profit of Associates

0.00

Minority Interest

2.01

Other related items

0.00

Consolidated Net Profit

368.75

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

9,778.58

Earnings per share (EPS)

0.25

Diluted Earnings per share

0.25

Operating Profit Margin (Excl OI)

18.80%

0.00

18.80%

Gross Profit Margin

29.73%

0.00

29.73%

PAT Margin

14.23%

0.00

14.23%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 257.74 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is 10.36% vs 7.21% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 20.00% vs -17.35% in Jun 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 36.87 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is -7.43% vs 371.69% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 237.95% vs -77.29% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 76.06 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is 42.14% vs 144.34% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 85.42% vs -45.46% in Jun 2025

Quarterly - Interest

Interest 5.85 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is -7.29% vs 8.61% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -1.52% vs 14.01% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.80%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025